D-glucose Increases the Synthesis of Tissue-type Plasminogen Activator (t-PA) in Human Peritoneal Mesothelial Cells

Summary

Physical and chemical irritation of the peritoneum through glucose-based hyperosmolar dialysis solutions results in a nonbacterial serositis with fibrinous exudation. Thereby, human peritoneal mesothelial cells (HMC) play an important role in maintaining the balance between the peritoneal generation and degradation of fibrin by expressing the fibrinolytic enzyme tissue-type plasminogen activator (t-PA) as well as the specific plasminogen activator inhibitor-1 (PAI-1). In this study, we analyzed the effect of D-glucose and metabolically inert monosaccharides on the synthesis of t-PA and PAI-1 in cultured HMC.

Incubation of HMC with D-glucose or the metabolically inert monosaccharides mannitol and L-glucose (5-90 mM) resulted in a time- and concentration-dependent increase in t-PA mRNA expression and antigen secretion without affecting PAI-1 synthesis. A similar effect was evident when HMC were first exposed sequentially to pooled spent peritoneal dialysis effluent for up to 4 hours, and subsequently incubated for 20 hours in control medium. The stimulating effect of high D-glucose on t-PA expression in HMC was prevented by treating the cells with different protein kinase C (PKC) inhibitors (Ro 31-8220, Gö 6976), but could not be mimicked by the PKC-activating phorbol ester PMA, indicating that this effect of high glucose is dependent on PKC activity, but not mediated through PKC activation. Also, using specific inhibitors (PD 98059, SB 203580) and activators (PMA, anisomycin, IL-1α) of the major routes of the mitogen-activated protein kinases (MAPKs) cascade, we found no evidence for a role of this cascade in regulating t-PA expression in HMC.

We conclude that hyperosmolarity induces t-PA (but not PAI-1) in HMC via a regulatory mechanism that requires active PKC, but that does not involve a major pathway in the MAPK cascade.

• References

• 1 Sitter T, Spannagl M, Schiffl H, Held E, van Hinsbergh VW, Kooistra T. Imbalance between intraperitoneal coagulation and fibrinolysis during peritonitis of CAPD patients: the role of mesothelial cells. Nephrol Dial Transplant 1995; 10: 677-83.
• 2 Sitter T, Toet K, Fricke H, Schiffl H, Held E, Kooistra T. Modulation of procoagulant and fibrinolytic system components of mesothelial cells by inflammatory mediators. Am J Physiol 1996; 271: R1256-63.
• 3 van Hinsbergh VW, Kooistra T, Scheffer MA, Hajo van Bockel J, van Muijen GN. Characterization and fibrinolytic properties of human omental tissue mesothelial cells. Comparison with endothelial cells. Blood 1990; 75: 1490-7.
• 4 Verhagen HJ, Heijnen Snyder GJ, Vink T, Pronk A, van Vroonhoven TJ, Eikelboom BC, Sixma JJ, de Groot PG. Tissue factor expression on mesothelial cells is induced during in vitro culture – manipulation of culture conditions creates perspectives for mesothelial cells as a source for cell seeding procedures on vascular grafts. Thromb Haemost 1995; 74: 1096-102.
• 5 Verhagen HJ, Heijnen Snyder GJ, Pronk A, Vroom TM, van Vroonhoven TJ, Eikelboom BC, Sixma JJ, de Groot PG. Thrombomodulin activity on mesothelial cells: perspectives for mesothelial cells as an alternative for endothelial cells for cell seeding on vascular grafts. Br J Haematol 1996; 95: 542-9.
• 6 Baricos WH, Cortez SL, el Dahr SS, Schnaper HW. ECM degradation by cultured human mesangial cells is mediated by a PA/plasmin/MMP-2 cascade. Kidney Int 1995; 47: 1039-47.
• 7 Breborowicz A, Oreopoulos DG. Biocompatibility of peritoneal dialysis solutions. Am J Kidney Dis 1996; 27: 738-43.
• 8 Breborowicz A, Rodela H, Oreopoulos DG. Toxicity of osmotic solutes on human mesothelial cells in vitro. Kidney Int 1992; 41: 1280-5.
• 9 Dobbie JW. Serositis: Comparative analysis of histolgical findings and pathogenetic mechanisms in nonbacterial serosal inflammation. Perit Dial Int 1993; 13: 256-69.
• 10 Goedde M, Sitter T, Schiffl H, Bechtel U, Schramm W, Spannagl M. Coagulation- and fibrinolysis-related antigens in plasma and dialysate of CAPD patients. Perit Dial Int 1997; 17: 162-6.
• 11 Vipond MN, Whawell SA, Thompson JN, Dudley HAF. Peritoneal fibrinolytic activity and intraabdominal adhesions. Lancet 1990; 335: 1120-2.
• 12 Dobbie JW, Jasani MK. Role of imbalance of intracavity fibrin formation and removal in the pathogenesis of peritoneal lesions in CAPD [editorial]. Perit Dial Int 1997; 17: 121-4.
• 13 Haneda M, Araki S, Togawa M, Sugimoto T, Isono M, Kikkawa R. Mitogen-activated protein kinase cascade Is activated in glomeruli of diabetic rats and glomerular mesangial cells cultured under high glucose conditions. Diabetes 1997; 46: 847-53.
• 14 Davis PD, Hill CH, Keech E, Lawton G, Nixon JS, Sedgwick AD, Wadsworth J, Westmacott D, Wilkinson SE. Potent selective inhibitors of protein kinase C. FEBS Lett 1989; 259: 61-3.
• 15 Martiny Baron G, Kazanietz MG, Mischak H, Blumberg PM, Kochs G, Hug H, Marme D, Schachtele C. Selective inhibition of protein kinase C isozymes by the indolocarbazole Go 6976. J Biol Chem 1993; 268: 9194-7.
• 16 Alessi DR, Cuenda A, Cohen P, Dudley DT, Saltiel AR. PD 098059 is a specific inhibitor of the activation of mitogen-activated protein kinase kinase in vitro and in vivo. J Biol Chem 1995; 270: 27489-94.
• 17 Cuenda A, Rouse J, Doza YN, Meier R, Cohen P, Gallagher TF, Young PR, Lee JC. SB 203580 is a specific inhibitor of a MAP kinase homologue which is stimulated by cellular stresses and interleukin-1. FEBS Lett 1995; 364: 229-33.
• 18 Mistry CD, Gokal R. The use of glucose polymer (icodextrin) in peritoneal dialysis: an overview. Perit Dial Int 1994; 14: S158-61.
• 19 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-9.
• 20 van Zonneveld AJ, Chang GT, van den Berg J, Kooistra T, Verheijen JH, Pannekoek H, Kluft C. Quantification of tissue-type plasminogen activator (t-PA) mRNA in human endothelial-cell cultures by hybridization with a t-PA cDNA probe. Biochem J 1986; 235: 385-90.
• 21 Fort P, Marty L, Piechaczyk M, el Sabrouty S, Dani C, Jeanteur P, Blanchard JM. Various rat adult tissues express only one major mRNA species from the glyceraldehyde-3-phosphate-dehydrogenase multigenic family. Nucleic Acids Res 1985; 13: 1431-42.
• 22 Witowski J, Topley N, Jorres A, Liberek T, Coles GA, Williams JD. Effect of lactate-buffered peritoneal dialysis fluids on human peritoneal mesothelial cell interleukin-6 and prostaglandin synthesis. Kidney Int 1994; 46: 282-93.
• 23 Sitter T, Haslinger B, Mandl S, Fricke H, Held E, Sellmayer A. High glucose increases prostaglandin E₂ synthesis in human peritoneal mesothelial cells: Role of hyperosmolarity. J Am Soc Nephrol 1998; 9: 2005-12.
• 24 Cohen P. The search for physiological substrates of MAP and SAP kinases in mammalian cells. Trends in Cell Biology 1997; 7: 353-61.
• 25 Cagliero E, Roth T, Roy S, Maiello M, Lorenzi M. Expression of genes related to the extracellular matrix in human endothelial cells. Differential modulation by elevated glucose concentrations, phorbol esters, and cAMP. J Biol Chem 1991; 266: 14244-50.
• 26 Maiello M, Boeri D, Podesta F, Cagliero E, Vichi M, Odetti P, Adezati L, Lorenzi M. Increased expression of tissue plasminogen activator and its inhibitor and reduced fibrinolytic potential of human endothelial cells cultured in elevated glucose. Diabetes 1992; 41: 1009-15.
• 27 Tada H, Tsukamoto M, Ishii H, Isogai S. A high concentration of glucose alters the production of tPA, uPA and PAI-1 antigens from human mesangial cells. Diabetes Res Clin Pract 1994; 24: 33-9.
• 28 Kollros PR, Konkle BA, Ambarian AP, Henrikson P. Plasminogen activator inhibitor-1 expression by brain microvessel endothelial cells is inhibited by elevated glucose. J Neurochem 1994; 63: 903-9.
• 29 Feener EP, Xia P, Inoguchi T, Shiba T, Kunisaki M, King GL. Role of protein kinase C in glucose- and angiotensin-II-induced plasminogen activator inhibitor expression. Contrib Nephrol 1996; 118: 180-7.
• 30 Levin EG, Santell L, Saljooque F. Hyperosmotic stress stimulates tissue plasminogen activator expression by a PKC-independent pathway. Am J Physiol 1993; 265: C387-96.
• 31 Dobbie JW. Morphology of the peritoneum in CAPD. Blood Purif 1989; 7: 74-85.